Sign In
Buy ISEE
$39.95
+0 (+0%)
At Close: Oct 09, 2023
IVERIC bio Reports Fourth Quarter and Year End 2019 Operational Highlights and Financial Results
12:00pm, Thursday, 27'th Feb 2020
IVERIC bio, Inc. announced financial and operating results for the fourth quarter and full year ended December 31, 2019 and provided a business update
Iveric bio: Much More Upside Ahead
01:16am, Wednesday, 12'th Feb 2020
Zimura stands to be a game-changer in the dry AMD indication. There are other promising assets in the company’s pipeline. Investors should consider these risks.
Allergan Reports Q4 Earnings Beat
12:00am, Monday, 10'th Feb 2020
Allergan plc (NYSE: AGN) reported quarterly earnings of $5.22 per share on Monday, beating the analyst consensus estimate of $4.57 by 14.22%.
This is a 21.68% increase over...
Wedbush Starts Iveric Bio Coverage With Bullish Rating On Zimura's Upcoming Pivotal Study
05:26pm, Tuesday, 07'th Jan 2020
Geographic atrophy is estimated to represent a market opportunity of over $1 billion, with the current patient population at more than 1 million, Nierengarten said in the note. In October, Iveric Bio
Hedge Funds Dropped The Ball On IVERIC bio, Inc. (ISEE)
12:58am, Tuesday, 24'th Dec 2019
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we've gathered as a result gives
Why Is IVERIC bio (ISEE) Up 79.1% Since Last Earnings Report?
04:30pm, Thursday, 12'th Dec 2019
IVERIC bio (ISEE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend
12:39pm, Friday, 06'th Dec 2019
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 5) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD )(present
IVERIC bio (ISEE) Q3 Loss Narrows Y/Y, Zimura Advancing Well
01:00pm, Wednesday, 13'th Nov 2019
IVERIC bio's (ISEE) third-quarter earnings improve year over year. The company plans to initiate a pivotal study on Zimura for treating GA early next year.
Other Barks & Bites, Friday, November 8
06:15pm, Friday, 08'th Nov 2019
his week in Other Barks & Bites: the Trump Administration sues Gilead for infringement over HIVE PrEP treatment patents; Senators Inhofe and Wicker ask President Trump to show no leniency on Chinese I
4 Best Vision Insurance Companies for 2020 • Benzinga
11:08am, Wednesday, 02'nd Oct 2019
Selecting the best vision insurance can seem complex. Benzinga's financial experts compare plans to help you make the best choice in 2020.
Vor Biopharma Completes $42M Series A Financing | FinSMEs
05:56pm, Thursday, 14'th Feb 2019
Vor Biopharma, an immuno-oncology company pioneering engineered hematopoietic stem cell therapies to treat hematological malignancies, raised $42m
10-year highs: Aus shares 0.4% higher at noon
07:10am, Tuesday, 08'th May 2018
08 May 2018 - Market at Midday: ASX200 back at 10-year highs. Retail trade remained steady in March in seasonally adjusted terms, disappointing economists who expected a rise of 0.3 per cent. Federal
CAR:T - Has biology outpaced the ability to deliver? -
01:32pm, Friday, 08'th Dec 2017
Experts comment on manufacturing of CAR-T
TXCELL nomme un expert de la thérapie génique à son Conseil scientifique
06:35am, Thursday, 25'th Aug 2016
(AOF) - TxCell, société de biotechnologies qui développe des immunothérapies cellulaires personnalisées innovantes à partir de cellules T régulatrices (Treg) pour le traitement de maladies infl
Travel insurance for pre-existing medical conditions made easy
11:21pm, Wednesday, 29'th Oct 2014
Need travel insurance for a pre-existing condition? Compare travel insurance and find cover for pregnancy, diabetes, cancer and more ✓
